Regulatory News
Tuesday, July 5, 2016
BRIEF-RedHill Biopharma, IntelGenx announce agreement for commercialization of RIZAPORT
* RedHill Biopharma and IntelGenx announce definitive
agreement for commercialization of RIZAPORT for migraines with
Grupo Juste in Spain and additional potential territories
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment